Genetic Technologies
GENE
#10097
Rank
A$5.93 M
Marketcap
$1.22
Share price
0.00%
Change (1 day)
-60.77%
Change (1 year)

Operating Margin for Genetic Technologies (GENE)

Operating Margin as of December 2024 (TTM): -137.10%

According to Genetic Technologies's latest financial reports and stock price the company's current Operating Margin is -137.10%. At the end of 2023 the company had an Operating Margin of -137.11%.

Operating Margin history for Genetic Technologies from 2004 to 2008

Operating Margin at the end of each year

Year Operating Margin Change
2023-137.11%30.06%
2022-105.42%-98.2%
2021-5,870.91%-90.8%
2020-63,815.64%152.7%
2019-25,253.91%774.73%
2018-2,887.06%78.13%
2017-1,620.78%57.99%
2016-1,025.84%134.26%
2015-437.90%97.22%
2014-222.04%-19.8%
2013-276.84%92.92%
2012-143.50%-849.47%
201119.15%-109.6%
2010-199.40%175.78%
2009-72.30%106.56%
2008-35.00%235.52%
2007-10.43%-80.57%
2006-53.71%-29.66%
2005-76.35%-57.62%
2004-180.17%895.39%
2003-18.10%-93.76%
2002-289.92%19.06%
2001-243.50%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-6,876.75% 4,915.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-20.72%-84.89%๐Ÿ‡บ๐Ÿ‡ธ USA
4.67%-103.41%๐Ÿ‡บ๐Ÿ‡ธ USA
11.66%-108.50%๐Ÿ‡บ๐Ÿ‡ธ USA
25.26%-118.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
21.11%-115.40%๐Ÿ‡บ๐Ÿ‡ธ USA
16.13%-111.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.46%-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.